- NCIt
- C4242
Loading cancer entity…
Loading cancer entity…
Clinical trials
461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00891657 | Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy | completed | N/A | 15 | Integra LifeSciences CorporationINDUSTRY | 1 | Sep 7, 2017 | clinicaltrials |
| NCT02835391 | PerClot Compared to Usual Care in Gynaecology Procedures | completed | N/A | 90 | CryoLife EuropaINDUSTRY | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03092999 |
| Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) |
| completed |
| Phase 1 |
| 36 |
| BayerINDUSTRY |
| 1 |
| Aug 18, 2017 |
| clinicaltrials |
| NCT02371811 | Use of v Care in Abdominal Hysterectomy | completed | N/A | 60 | Ain Shams Maternity HospitalOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00332033 | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) | completed | Phase 2 | 32 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01946178 | Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids | completed | N/A | 73 | Mirabilis Medica, Inc.INDUSTRY | 1 | May 30, 2017 | clinicaltrials |
| NCT01412489 | Intrauterine Adhesion Rate After Hysteroscopic Myomectomy and Application of HYALOBARRIER Gel(HYGEM) | completed | N/A | 189 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT01936493 | Biologic Predictors of Leiomyoma Treatment Outcomes | completed | — | 38 | Elizabeth A. StewartOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT02635789 | Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | completed | Phase 3 | 62 | NobelpharmaINDUSTRY | 1 | Feb 2, 2017 | clinicaltrials |
| NCT02997787 | New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma | completed | — | 60 | Kayseri Education and Research HospitalOTHER_GOV | 0 | Dec 26, 2016 | clinicaltrials |
| NCT01852734 | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | completed | N/A | 52 | Odense University HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02465814 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids(ASTEROID 2) | completed | Phase 2 | 120 | BayerINDUSTRY | 16 | Nov 22, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT01592903 | Somatic Stem Cells in Leiomyomas? | completed | — | 16 | IgenomixINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02819609 | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | completed | — | 12,234 | Quintiles, Inc.INDUSTRY | 0 | Jun 30, 2016 | clinicaltrials |
| NCT01156857 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIII) | completed | Phase 3 | 209 | PregLem SAINDUSTRY | 4 | Jan 15, 2016 | clinicaltrials |
| NCT01252069 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | completed | Phase 3 | 132 | PregLem SAINDUSTRY | 4 | Jan 13, 2016 | clinicaltrials |
| NCT01642472 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLext2) | completed | Phase 3 | 64 | PregLem SAINDUSTRY | 4 | Jan 8, 2016 | clinicaltrials |
| NCT02620345 | Fibroids in Women of Reproductive Age and Women Pregnancy(Fibroids) | completed | Phase 4 | 22 | Trieu, Nguyen Thi, M.D.INDIV | 0 | Dec 3, 2015 | clinicaltrials |
| NCT01588899 | China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids | completed | N/A | 107 | Philips HealthcareINDUSTRY | 1 | Oct 22, 2015 | clinicaltrials |
| NCT01229826 | Magnetic Resonance Elastography (MRE) of Uterine Fibroids(MRE) | completed | — | 134 | Mayo ClinicOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT02086370 | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques(Rad_PBS) | completed | N/A | 177 | University Magna GraeciaOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01123603 | Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata(LOTUS) | completed | — | 860 | The Cleveland ClinicOTHER | 1 | Jan 14, 2015 | clinicaltrials |
| NCT02049242 | Uterine Tourniquet at Open Myomectomy | completed | N/A | 48 | Ataturk UniversityOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT02086279 | AMH Levels Change During Treatment With GnRh Agonist | completed | N/A | 67 | University Magna GraeciaOTHER | 1 | Nov 25, 2014 | clinicaltrials |
| NCT00886873 | Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids(Mifemyo_2) | completed | Phase 2 / Phase 3 | 100 | Mediterranea Medica S. L.OTHER | 1 | Oct 17, 2014 | clinicaltrials |
| NCT01451424 | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT02061657 | Impact of Misoprostol on Blood Loss In Myomectomy Operations | completed | Phase 3 | 50 | Ain Shams UniversityOTHER | 1 | Aug 12, 2014 | clinicaltrials |
| NCT00882258 | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | completed | Phase 2 | 144 | Repros Therapeutics Inc.INDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00874029 | Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids(Halt) | completed | N/A | 137 | Acessa Health, Inc.INDUSTRY | 3 | Jul 3, 2014 | clinicaltrials |
| NCT01829022 | Multi-center Prospective Study on E-NOTES for Myomectomy With Traction of Multidirectional Sutures(E-NOTES) | completed | — | 35 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 26, 2014 | clinicaltrials |
| NCT02166554 | The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions(BAP) | completed | Phase 1 / Phase 2 | 216 | BioRegen Biomedical (Changzhou) Co., LtdINDUSTRY | 1 | Jun 18, 2014 | clinicaltrials |
| NCT01816815 | Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 | completed | Phase 1 | 73 | BayerINDUSTRY | 3 | Apr 21, 2014 | clinicaltrials |
| NCT01631903 | Extension of Study ZPV-200 | completed | Phase 2 | 48 | Repros Therapeutics Inc.INDUSTRY | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01739621 | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200 | completed | Phase 2 | 40 | Repros Therapeutics Inc.INDUSTRY | 0 | Apr 16, 2014 | clinicaltrials |
| NCT00485355 | Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy | completed | N/A | 27 | The Cleveland ClinicOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01032213 | Effect of Magnesium Sulphate on Coagulation | completed | N/A | 40 | Seoul National University Bundang HospitalOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01261429 | Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) | completed | Phase 2 | 50 | Centre Leon BerardOTHER | 5 | Apr 16, 2013 | clinicaltrials |
| NCT01452659 | Efficacy and Safety of TAK-385 in the Treatment of Uterine Fibroids | completed | Phase 2 | 216 | TakedaINDUSTRY | 1 | Jan 21, 2013 | clinicaltrials |
| NCT00881140 | Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids | completed | Phase 2 | 30 | BioPro Medical LtdINDUSTRY | 1 | Dec 19, 2012 | clinicaltrials |
| NCT00837161 | Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids | completed | Phase 1 / Phase 2 | 11 | Philips HealthcareINDUSTRY | 1 | Dec 4, 2012 | clinicaltrials |
| NCT00897897 | Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids | completed | N/A | 33 | Philips HealthcareINDUSTRY | 4 | Dec 4, 2012 | clinicaltrials |
| NCT01707862 | Surgery for Intravenous Leiomyomatosis(SIVL) | completed | — | 6 | Li YangOTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00628901 | A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) | completed | Phase 4 | 60 | Boston Scientific CorporationINDUSTRY | 1 | Jul 11, 2012 | clinicaltrials |
| NCT01581944 | Gonadotropin-releasing Hormone Agonist Prior to Myomectomy | completed | Phase 3 | 68 | Mt. Hope Maternity HospitalOTHER | 1 | Apr 20, 2012 | clinicaltrials |
| NCT01031901 | Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) | completed | Phase 1 | 52 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT01092988 | A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 40 | InSightecINDUSTRY | 4 | Feb 22, 2012 | clinicaltrials |
| NCT01530802 | Temporary Clipping of the Uterine Arteries During Laparoscopic Myomectomy | completed | N/A | 166 | Charite University, Berlin, GermanyOTHER | 1 | Feb 10, 2012 | clinicaltrials |
| NCT01468402 | Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma | completed | — | 50 | Hospital Israelita Albert EinsteinOTHER | 1 | Nov 9, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Sep 7, 2017source: clinicaltrials